Feature-by-feature breakdown vs Medisafe, MyTherapy, Pill Reminder, and Round Health. The market intelligence for winning the on-device AI medication adherence space.
Four main players in the medication reminder and adherence space — the market leader, the free pharma-funded contender, the simple one-time-purchase option, and the abandoned design darling.
Every MedInsight feature is labeled FREE or PRO ($4.99 one-time unlock).
| Feature | MedInsight | Medisafe | MyTherapy | Pill Reminder |
|---|---|---|---|---|
| Medication reminders | ✅ FREE | ⚠️ Free (2 meds limit as of Jan 2026) | ✅ Free | ✅ $1.99 one-time |
| HealthKit Medications API (auto-import) | ✅ FREE — no manual entry | ❌ Not implemented | ❌ Not implemented | ❌ Not implemented |
| Medication count limit (free tier) | ✅ Unlimited (via HealthKit) | ❌ 2 medications max (Jan 2026) | ✅ Unlimited | ⚠️ Limited on free |
| Offline / on-device only | ✅ 100% on-device (Foundation Models) | ❌ Cloud-dependent | ❌ Cloud-dependent | ✅ Local only |
| Caregiver / dependent profiles | ✅ PRO — family plan | ⚠️ 1 free, unlimited at $4.99/mo | ✅ Free | ❌ No |
| Refill reminders | ✅ FREE | ✅ Free (limited) | ✅ Free | ❌ No |
| Feature | MedInsight | Medisafe | MyTherapy | Pill Reminder |
|---|---|---|---|---|
| AI medication explainer (plain English) | ✅ FREE — Foundation Models on-device | ❌ Not available | ❌ Not available | ❌ Not available |
| Drug interaction checker | ✅ PRO — on-device safety check | ❌ Not available | ❌ Not available | ❌ Not available |
| Adherence coaching (AI-powered) | ✅ PRO — personalized nudges | ❌ No AI coaching | ❌ No AI coaching | ❌ No AI coaching |
| Side effects explained in context | ✅ FREE — per-medication AI summaries | ❌ Not available | ❌ Not available | ❌ Not available |
| Why you take this medication (plain language) | ✅ FREE — AI explains mechanism | ❌ Not available | ❌ Not available | ❌ Not available |
| Privacy — prescription data on-device only | ✅ Zero data leaves device | ❌ Cloud storage required | ❌ Cloud storage — pharma partner | ✅ Local only (limited) |
| Feature | MedInsight | Medisafe | MyTherapy | Pill Reminder |
|---|---|---|---|---|
| Adherence report export for doctors | ✅ PRO — PDF export | ⚠️ Premium only ($4.99/mo) | ✅ Free — basic report | ❌ Not available |
| HealthKit write-back (log doses to Health app) | ✅ FREE | ⚠️ Limited integration | ❌ Not available | ❌ Not available |
| MedFriend / emergency contact alerts | ✅ PRO | ⚠️ Free (limited); Premium: unlimited | ❌ Not available | ❌ Not available |
| Feature | MedInsight | Medisafe | MyTherapy | Pill Reminder |
|---|---|---|---|---|
| Home screen widget | ✅ FREE — next dose + streak | ⚠️ Basic widget only | ❌ No widget | ❌ No widget |
| Apple Watch complication | ✅ PRO — glance + haptic alert | ❌ Not available | ❌ Not available | ❌ Not available |
| Siri Shortcuts ("Did I take my metformin?") | ✅ PRO | ❌ Not available | ❌ Not available | ❌ Not available |
| Live Activity (Dynamic Island notification) | ✅ FREE — dose due alert | ❌ Not available | ❌ Not available | ❌ Not available |
| Reliable notifications (no delay) | ✅ On-device — immediate | ❌ 4-hr delays on free tier (verified complaint) | ⚠️ Notification reliability issues reported | ✅ Local — generally reliable |
| Factor | MedInsight | Medisafe | MyTherapy | Pill Reminder |
|---|---|---|---|---|
| Business model | One-time $4.99 Pro Unlock | $4.99/mo recurring subscription | Free — pharma data monetization | $1.99 one-time (basic) |
| Ads-free experience | ✅ Always — no ads ever | ❌ Ads on free tier (verified complaint) | ✅ No ads | ✅ After one-time purchase |
| Data used for pharma/third parties | ✅ Zero — fully on-device | ❌ Cloud stored; data policy concerns | ❌ Bayer subsidiary — pharma partner data | ✅ Local only |
| Free tier quality in 2026 | High — full HealthKit AI for unlimited meds | Low — 2 medications only as of Jan 2026 | Medium — full reminders, complex UI | Low — reminders only, no intelligence |
Free tier gives chronic patients genuine on-device AI help. Pro unlocks safety intelligence and deep health system integration.
Free users get AI-explained medications better than anything on the market. The Pro upgrade hook is drug interaction checking — a clinical safety feature that every multi-medication patient needs. "You're taking 6 medications. Would you like to check for interactions?" This is a near-instant conversion for anyone on polypharmacy (3+ medications), which describes the majority of MedInsight's target users.
MedInsight's one-time $4.99 model is uniquely positioned — better than Medisafe's aggressive $60/yr subscription, more transparent than MyTherapy's pharma data model, and more capable than Pill Reminder's basic $1.99 entry.
Ads on free. 4-hr notification delays on free. No AI. Locked free users to 2 meds in Jan 2026 — triggering mass complaint wave.
Bayer subsidiary. Pharma partner data model. Notification unreliability. No AI. Complex UI.
~6K downloads/mo, ~$5K/mo revenue (Sensor Tower). Simple reminders only. No interaction checking, no HealthKit API, no AI.
Best free tier in market. One-time Pro unlock. Zero data leaves device. No subscription pressure. AI features competitors don't have at any price.
Free tier (post Jan 2026)
Premium — $4.99/mo or $39.99/yr
Locking free users to 2 medications is catastrophic UX for a demographic (chronic patients on 5-10 daily medications) that literally cannot use the app anymore without paying. Review scores dropped sharply in early 2026. MedInsight's unlimited HealthKit-imported medications on the free tier is a direct, winnable counter-positioning to Medisafe's most complained-about decision. The migration window is now.
What's free for the user
What it costs (the real business model)
MyTherapy is free because Bayer's pharma network pays for medication adherence analytics. For privacy-conscious patients — especially those on sensitive medications (mental health, HIV, hormonal, addiction treatment) — this is a hard no. MedInsight's 100% on-device Foundation Models approach is a direct answer: the AI explains your medications using your data, on your device, and nothing leaves. Privacy is a genuine health concern, not just a feature.
Medisafe locked free users to 2 medications in January 2026. MedInsight reads all your medications directly from Apple Health — no cap, no subscription. Pay $4.99 once and it's yours for life.
Medisafe shows ads in between your medication reminders on the free tier. MedInsight has no ads. Ever. Health is not an ad surface.
MyTherapy is owned by Bayer. Your medication habits feed pharma partner analytics. MedInsight's AI runs entirely on your device. Your prescriptions never leave your phone — not to us, not to anyone.
MyTherapy reminds you to take medications but never tells you why. MedInsight's on-device AI explains every medication in plain English — side effects, mechanism, and what to watch for. Your doctor in your pocket.
Medisafe charges $40/yr and shows you ads. MyTherapy is free because it sells your data to pharma. Pill Reminder is just an alarm clock. MedInsight reads your medications from Apple Health, explains every drug in plain language using on-device AI, alerts you to potential interactions, and never sends your prescription data to the cloud. One $4.99 unlock. No subscription. No ads. No data selling. Built for the 50% of chronic patients who aren't taking their medications because nobody ever explained why they should.
| Competitive Lever | How MedInsight Wins | Competitor It Beats |
|---|---|---|
| Zero-friction onboarding | HealthKit API reads all meds automatically | All competitors (all require manual entry) |
| AI medication explainer | Foundation Models — on-device, no cloud | All competitors (none have this) |
| Privacy | 100% on-device — zero data leaves phone | Medisafe (cloud) + MyTherapy (pharma data) |
| Pricing fairness | $4.99 one-time vs $39.99/yr recurring | Medisafe ($39.99/yr subscription) |
| Free tier quality | Unlimited meds + AI — no caps | Medisafe (2-med cap Jan 2026) |
| Apple Watch | Only medication app with Watch complication | All competitors (none have Watch app) |
| Migration trigger | Medisafe anger = ready audience now | First-mover advantage on Medisafe exodus |